F644-0523 Screening compound: 1-{[1,4'-bipiperidin]-1'-yl}-3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-1H-pyrazol-4-yl}propan-1-one

F644-0523 Screening compound: 1-{[1,4'-bipiperidin]-1'-yl}-3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-1H-pyrazol-4-yl}propan-1-one
F644-0523 Screening compound: 1-{[1,4'-bipiperidin]-1'-yl}-3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-1H-pyrazol-4-yl}propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F644-0523
1-{[1,4'-bipiperidin]-1'-yl}-3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-1H-pyrazol-4-yl}propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F644-0523

Molecular Formula

C26H39N7O2 (C26 H39 N7 O2)

Compound Name

1-{[1,4'-bipiperidin]-1'-yl}-3-{3,5-dimethyl-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-1H-pyrazol-4-yl}propan-1-one

IUPAC name

1-{[14'-bipiperidin]-1'-yl}-3-{35-dimethyl-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-1H-pyrazol-4-yl}propan-1-one

SMILES

Cc1c(CCC(N(CC2)CCC2N2CCCCC2)=O)c(C)nn1-c1ncnc(N2CCOCC2)c1

InChI

InChI=1S/C26H39N7O2/c1-20-23(6-7-26(34)32-12-8-22(9-13-32)30-10-4-3-5-11-30)21(2)33(29-20)25-18-24(27-19-28-25)31-14-16-35-17-15-31/h18-19,22H,3-17H2,1-2H3

InChI Key

CFWBQYKCBSPTOE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27182067

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

481.64

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.770

Distribution Coefficient, logD

-0.786

Water Solubility, LogSw

-2.88

Polar Surface Area

63.969

Acid Dissociation Constant (pKa)

21.37

Base Dissociation Constant (pKb)

10.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

69.20

F644-0523 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F644-0523 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F644-0523?
Check Price and Availability of F644-0523, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F644-0523 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F644-0523
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F644-0523
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F644-0523 available by request